BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26918053)

  • 1. Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions.
    Ben-Eltriki M; Deb S; Guns ES
    J Cancer; 2016; 7(4):391-407. PubMed ID: 26918053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
    Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
    Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
    Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
    J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-related therapies in prostate cancer.
    Johnson CS; Hershberger PA; Trump DL
    Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer.
    Ben-Eltriki M; Deb S; Shankar G; Meckling G; Hassona M; Yamazaki T; Fazli L; Chin MY; Tomlinson Guns ES
    Medicines (Basel); 2021 Jun; 8(6):. PubMed ID: 34199743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer.
    Peehl DM; Seto E; Feldman D
    Urology; 2001 Aug; 58(2 Suppl 1):123-6. PubMed ID: 11502466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM; Seto E; Hsu JY; Feldman D
    J Urol; 2002 Oct; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D metabolism and action in the prostate: implications for health and disease.
    Swami S; Krishnan AV; Feldman D
    Mol Cell Endocrinol; 2011 Dec; 347(1-2):61-9. PubMed ID: 21664249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
    Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
    Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
    Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
    Yin Y; Ni J; Chen M; Guo Y; Yeh S
    Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer--new aspects of tumor biology: are calcitriol and cyclooxygenase-2 possible targets for breast cancer?
    Thill M; Terjung A; Friedrich M
    Eur J Gynaecol Oncol; 2014; 35(4):341-58. PubMed ID: 25118473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update.
    Segovia-Mendoza M; García-Quiroz J; Díaz L; García-Becerra R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
    Wang JY; Swami S; Krishnan AV; Feldman D
    Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol and cancer therapy: A missed opportunity.
    Trump DL
    Bone Rep; 2018 Dec; 9():110-119. PubMed ID: 30591928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.
    Dunlap N; Schwartz GG; Eads D; Cramer SD; Sherk AB; John V; Koumenis C
    Br J Cancer; 2003 Aug; 89(4):746-53. PubMed ID: 12915889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
    Krishnan AV; Swami S; Feldman D
    J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D in prostate cancer.
    Trump DL; Aragon-Ching JB
    Asian J Androl; 2018; 20(3):244-252. PubMed ID: 29667615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D in Prostate Cancer.
    Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
    Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.